STEREOTAXIS STXS 深 沪
已收盘 02-06 16:00:00 美东时间
2.03
+0.050
+2.53%
华盛通- 最 高2.06
- 今 开2.03
- 成交量 47.89万股
- 最 低 1.98
- 昨 收 1.98
- 总市值 1.89亿
- 52周最高 3.59
- 市盈率 静 --
- 换手率 0.51%
- 52周最低 1.54
- 委 比 83.61%
- 总股本 9332.48万
- 历史最高 10.30
- 量 比 0.63
- 振 幅 4.04%
- 历史最低 1.33
- 每 手 1
- 风险率 0.40%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Stereotaxis shares are trading higher after the company announced it received FDA approval for its MAGiC Magnetic Interventional Ablation Catheter.
Stereotaxis shares are trading higher after the company announced it received F...
01-06 22:24
Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter
Stereotaxis has received FDA approval for its MAGiC Magnetic Interventional Ablation Catheter, a robotic catheter designed for minimally invasive cardiac ablation procedures. The approval marks a significant milestone in robotic cardiac ablation technology, offering enhanced precision and stability for treating complex heart rhythm disorders. The catheter is particularly beneficial for underserved patient populations with limited access to conven...
01-06 13:01
美股大行评级 | 潜在涨幅263.64%！Milestone Pharmaceuticals获富国银行升目标价至8美元，维持"超配"评级
今日重点评级关注：富国银行：维持Milestone Pharmaceuticals"超配"评级，目标价从4美元升至8美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从31美元升至33美元
2025-12-17 10:46
Citizens Initiates Coverage On Stereotaxis with Market Outperform Rating, Announces Price Target of $4
Citizens analyst Daniel Stauder initiates coverage on Stereotaxis (AMEX:STXS) with a Market Outperform rating and announces Price Target of $4.
2025-12-16 19:20
Stereotaxis to Participate in Piper Sandler 37th Annual Healthcare Conference
<p>Stereotaxis, a leader in surgical robotics for minimally invasive procedures, announced its participation in the Piper Sandler 37th Annual Healthcare Conference. David Fischel, CEO and Chairman, will engage in a fireside discussion on December 3, 2025, and hold one-on-one meetings the same day. Fischel highlighted the company's achievements in regulatory milestones and early commercial growth, expressing enthusiasm for investor engagement at t...
2025-11-24 13:58
美股大行评级 | 富国银行上调AMD目标价升至345美元；花旗上调礼来目标价升至1500美元；巴克莱上调腾讯音乐目标价升至28美元
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从12美元升至15美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从106美元升至107美元
2025-11-13 09:58
Stereotaxis Earnings Call: Growth Amid Challenges
Stereotaxis (($STXS)) has held its Q3 earnings call. Read on for the main highl...
2025-11-13 08:28
Roth Capital Reiterates Buy on Stereotaxis, Maintains $4 Price Target
Roth Capital analyst Kyle Bauser reiterates Stereotaxis (AMEX:STXS) with a Buy and maintains $4 price target.
2025-11-13 01:45
Stereotaxis shares are trading lower after the company reported worse-than-expected Q3 financial results.
Stereotaxis shares are trading lower after the company reported worse-than-expe...
2025-11-12 05:13
Stereotaxis Q3 EPS $(0.07) Misses $(0.06) Estimate, Sales $7.464M Miss $8.375M Estimate
Stereotaxis (AMEX:STXS) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.06) by 16.67 percent. This is a 12.5 percent increase over losses of $(0.08) per share from the
2025-11-12 05:07
